State of Wisconsin Investment Board
RXRX icon

State of Wisconsin Investment Board’s Recursion Pharmaceuticals RXRX Stock Holding History

State of Wisconsin Investment Board’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$761K Buy
248,011
+80,137
+48% +$310K ﹤0.01% 1804
2025
Q4 		$687K Sell
167,874
-10,477
-6% -$51.9K ﹤0.01% 1807
2025
Q3 		$870K Buy
178,351
+1,342
+0.8% +$7.05K ﹤0.01% 1668
2025
Q2 		$896K Buy
177,009
+4,894
+3% +$24K ﹤0.01% 1622
2025
Q1 		$910K Buy
172,115
+1,460
+0.9% +$10.6K ﹤0.01% 1521
2024
Q4 		$1.15M Buy
170,655
+78,326
+85% +$527K ﹤0.01% 1468
2024
Q3 		$608K Sell
92,329
-8,225
-8% -$59K ﹤0.01% 1783
2024
Q2 		$754K Sell
100,554
-4,572
-4% -$39.9K ﹤0.01% 1643
2024
Q1 		$1.05M Sell
105,126
-2,504
-2% -$27.9K ﹤0.01% 1417
2023
Q4 		$1.06M Sell
107,630
-2,169
-2% -$15.5K ﹤0.01% 1377
2023
Q3 		$840K Sell
109,799
-2,485
-2% -$24.8K ﹤0.01% 1460
2023
Q2 		$839K Buy
112,284
+61,973
+123% +$434K ﹤0.01% 1532
2023
Q1 		$336K Buy
50,311
+4,130
+9% +$32.8K ﹤0.01% 2041
2022
Q4 		$356K Sell
46,181
-26,342
-36% -$258K ﹤0.01% 2034
2022
Q3 		$772K Buy
72,523
+27,879
+62% +$282K ﹤0.01% 1690
2022
Q2 		$363K Sell
44,644
-107,656
-71% -$720K ﹤0.01% 2236
2022
Q1 		$1.09M Hold
152,300
– – ﹤0.01% 1626
2021
Q4 		$2.61M Buy
152,300
+125,000
+458% +$2.35M 0.01% 1207
2021
Q3 		$628K Hold
27,300
– – ﹤0.01% 1616
2021
Q2 		$996K Buy
+27,300
New +$808K ﹤0.01% 1455

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State of Wisconsin Investment Board's RXRX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Recursion Pharmaceuticals (RXRX) stake by 48% in Q1 2026, buying an estimated $310K and bringing the position to 248,011 shares worth $761K. The position accounts for ﹤0.01% of the portfolio, ranked #1804.

State of Wisconsin Investment Board first reported a position in RXRX in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.61M in Q4 2021. 335 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • State of Wisconsin Investment Board held 248,011 shares of Recursion Pharmaceuticals worth $761K as of Q1 2026.
  • State of Wisconsin Investment Board bought 80,137 Recursion Pharmaceuticals shares in Q1 2026, an estimated $310K.
  • Recursion Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1804 holding.
  • State of Wisconsin Investment Board first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • State of Wisconsin Investment Board's Recursion Pharmaceuticals position peaked at $2.61M in Q4 2021.
  • 335 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.